Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

Author: Avi Kapoor | April 25, 2024 07:54am

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Pfizer Inc. (NYSE:PFE)

  • Dividend Yield: 6.40%
  • Guggenheim analyst Vamil Divan initiated coverage on the stock with a Buy rating and a price target of $36 on Feb. 23, 2024. This analyst has an accuracy rate of 76%.
  • TD Cowen analyst Steve Scala downgraded the stock from Outperform to Market Perform with a price target of $32 on Jan. 4, 2024. This analyst has an accuracy rate of 73%.
  • Recent News: On April 24, Pfizer's board of directors declared a 42 cents second-quarter 2024 dividend on the company’s common stock.

Gilead Sciences, Inc. (NASDAQ:GILD)

  • Dividend Yield: 4.59%
  • Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and cut the price target from $84 to $78 on March 4, 2024. This analyst has an accuracy rate of 76%.
  • RBC Capital analyst Brian Abrahams maintained a Sector Perform rating and slashed the price target from $76 to $75 on Feb. 14, 2024. This analyst has an accuracy rate of 62%.
  • Recent News: Gilead Sciences is expected to release first quarter 2024 financial results on Thursday, April 25.

Patterson Companies, Inc. (NASDAQ:PDCO)

  • Dividend Yield: 3.97%
  • Morgan Stanley analyst Erin Wright maintained an Equal-Weight rating and cut the price target from $38 to $35 on Nov. 30, 2023. This analyst has an accuracy rate of 77%.
  • Stifel analyst Jonathan Block reiterated a Hold rating with a price target of $32 on Nov. 28, 2023. This analyst has an accuracy rate of 76%.
  • Recent News: On March 11, Patterson Companies approved a $500 million stock buyback and declared a quarterly dividend of 26 cents per share.

Read More: Jim Cramer Says This Energy Stock Is ‘Terrific,’ Calls Casey’s General Stores A ‘Winner’

Posted In: GILD PDCO PFE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist